Invention Grant
- Patent Title: Use of interference peptide in preparation of anti-SARS-CoV-2 medicament
-
Application No.: US17428024Application Date: 2020-06-22
-
Publication No.: US12076364B2Publication Date: 2024-09-03
- Inventor: Ren Lai , Xiaopeng Tang , Zhiyi Liao
- Applicant: KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
- Applicant Address: CN Yunnan
- Assignee: KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
- Current Assignee: KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
- Current Assignee Address: CN Yunnan
- Agency: MH2 TECHNOLOGY LAW GROUP, LLP
- International Application: PCT/CN2020/097446 2020.06.22
- International Announcement: WO2021/258250A 2021.12.30
- Date entered country: 2021-08-03
- Main IPC: A61K38/08
- IPC: A61K38/08 ; A61K38/07 ; A61K38/10 ; A61P31/14 ; C07K7/06 ; C07K7/08
Abstract:
An agent for inhibiting binding of transferrin receptor to SARS-CoV-2 spike protein or an anti-SARS-CoV-2 medicament is provided, where active pharmaceutical ingredients of the agent or the medicament include interference peptides, and the interference peptides include: SL8, FG8, DL12, RK4, SD6, HF7, and/or QK8.
Public/Granted literature
- US20220323537A1 USE OF INTERFERENCE PEPTIDE IN PREPARATION OF ANTI-SARS-CoV-2 MEDICAMENT Public/Granted day:2022-10-13
Information query
IPC分类:
